ArticlePediatric cardiology2026
External Validation of the PLASE Score Prediction Model for PDA Surgery.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The PLASE score-a predictive model for subsequent patent ductus arteriosus (PDA) surgery using simple echocardiographic indices on day 3-has demonstrated strong predictive ability. To our knowledge, no predictive model for PDA surgery has undergone external validation. This study aimed to externally validate and update the PLASE score using an independent cohort. The PLASE score was applied to a validation dataset comprising infants admitted to Kanagawa Children's Medical Center between 2019 and 2024 with a gestational age of 23 to 29 weeks. Discriminative performance was assessed using the area under the receiver operating characteristic curve (ROC-AUC) and the Brier score. Calibration analysis was also conducted. The PLASE score was subsequently updated using the entire dataset. The validation cohort included 127 patients-23 who underwent PDA surgery and 104 who did not. The PLASE score exhibited good discriminative ability, with a ROC-AUC of 0.833 (95% confidence interval [CI], 0.755-0.911) and a Brier score of 0.125. After model updating, the ROC-AUC improved to 0.846 (95% CI, 0.810-0.882). The PLASE score demonstrated high predictive performance in this external validation cohort. Based on the integrated dataset, a revised model (PLASE score version 2) was developed, offering a more robust and clinically applicable tool for current neonatal care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.